Clinical trial
Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate…
NCT00264927 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00264927 |
|---|---|
| Title | Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion |
| Official title | A Randomized, Double-Blind, Placebo-Group, Multicenter Study Evaluating the Efficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion |
| Acronym | SIADH |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Inappropriate ADH Syndrome, Hyponatremia |
| Intervention type | Drug |
| Interventions | SR121463B |
| Enrollment | 77 |
| Start date | May 1, 2004 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Dec 13, 2005 |
| Last update posted | Dec 10, 2008 |
| Countries | Belgium, Brazil, Canada, Croatia, Germany, Hong Kong, Hungary, Netherlands, Portugal, Spain, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: